Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2018-19 | Page 103

Amount in Taka

### 30. Finance Cost

| Particulars | Note | July 2018-June 2019 | July 2017-June 2018 |
|---|---|---|---|
| Interest on Working Capital Loan | | 797,139,744 | 378,949,336 |
| Interest on Long Term Loan | | 27,718,969 | (10,909,700) |
| Interest on Lease Finance | | 60,109,947 | 73,787,122 |
| Interest on Loan from PF, WPPF & Welfare Fund | | 128,075,983 | 85,080,425 |
| Other Bank Charges | | 16,717,899 | 13,376,260 |
| **Total** | | **1,029,762,542** | **540,283,443** |

### 31. Income Tax Expenses

This consists of as follows :

| Particulars | Note | July 2018-June 2019 | July 2017-June 2018 |
|---|---|---|---|
| (a) Current Tax | | 803,760,846 | 792,620,241 |
| (b) Deferred Tax Expense | | 101,901,936 | 36,059,589 |
| **Total** | | **905,662,782** | **828,679,830** |

### 32. Earnings Per Share (EPS)

| Particulars | Note | July 2018-June 2019 | July 2017-June 2018 |
|---|---|---|---|
| (a) Earnings attributable to the Owners of the Company | | 3,033,402,333 | 2,536,543,948 |
| (b) Weighted average number of Shares outstanding during the year | | 405,556,445 | 405,556,445 |
| **Earnings Per Share (EPS)** | | **7.48** | **6.25** |

### 33. Net Asset Value (NAV) Per Share

| Particulars | Note | June 30, 2019 | June 30, 2018 |
|---|---|---|---|
| Total Assets | | 49,214,092,360 | 43,738,886,412 |
| Less Total Liabilities | | (19,349,768,523) | (16,387,049,620) |
| Less Non-controlling Interest | | (276,006,553) | (269,874,176) |
| **Equity Attributable to the Owners of the Company** | | **29,588,317,284** | **27,081,962,616** |
| Number of Ordinary Shares at Financial Position date | | 405,556,445 | 405,556,445 |
| **Net Asset Value (NAV) Per Share** | | **72.96** | **66.78** |

### 34. Net Operating Cash Flow Per Share (NOCFPS)

| Particulars | Note | July 2018-June 2019 | July 2017-June 2018 |
|---|---|---|---|
| Net Cash Generated from Operating Activities | | 2,959,916,904 | 1,819,113,923 |
| Number of Ordinary Shares at Financial Position date | | 405,556,445 | 405,556,445 |
| **Net Operating Cash Flow Per Share (NOCFPS)** | | **7.30** | **4.49** |